BioCardia Director Marvin Slosman Granted 8,000 Stock Options

BioCardia, Inc. director Marvin Slosman was granted 8,000 stock options on July 6, 2026, with an exercise price of $1.20 per share. The options have a 10-year term expiring on July 6, 2036, and vesting is contingent on continued service through the one-year anniversary of the grant date. Following this transaction, Slosman holds a total of 20,000 stock options. The filing represents a Form 4 disclosure of director equity compensation and was filed on July 7, 2026, with David McClung signing by power of attorney. This transaction is part of the company's standard equity compensation program for directors.